JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 52 filers reported holding JUNIPER PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $116,000 | -10.8% | 20,792 | -11.1% | 0.01% | 0.0% |
| Q3 2016 | $130,000 | -45.4% | 23,392 | -31.0% | 0.01% | -46.2% |
| Q2 2016 | $238,000 | -72.1% | 33,906 | -73.8% | 0.01% | -75.9% |
| Q1 2016 | $854,000 | -52.4% | 129,176 | -25.8% | 0.05% | -38.6% |
| Q4 2015 | $1,793,000 | +51.3% | 174,064 | +73.1% | 0.09% | +51.7% |
| Q3 2015 | $1,185,000 | +174.3% | 100,564 | +112.8% | 0.06% | +241.2% |
| Q2 2015 | $432,000 | – | 47,256 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
| Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
| EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
| PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
| TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
| Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
| Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |